Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Omega Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
OMGA
Nasdaq
8731
https://omegatherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Omega Therapeutics Inc
Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- Apr 17th, 2024 1:55 pm
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control
- Apr 9th, 2024 11:00 am
Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know
- Apr 3rd, 2024 4:00 pm
We Think Omega Therapeutics (NASDAQ:OMGA) Needs To Drive Business Growth Carefully
- Mar 29th, 2024 12:22 pm
Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates
- Mar 28th, 2024 2:25 pm
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update
- Mar 28th, 2024 1:15 pm
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024
- Mar 6th, 2024 12:00 pm
The 3 Best Biotech Stocks to Buy in January 2024
- Jan 10th, 2024 4:01 am
Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk
- Jan 5th, 2024 5:55 pm
Novo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs
- Jan 5th, 2024 3:35 pm
Why Novo Nordisk Stock Crushed the Market Today
- Jan 4th, 2024 11:08 pm
Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity
- Jan 4th, 2024 9:01 pm
Novo Nordisk enters research partnerships with biotech firms
- Jan 4th, 2024 3:02 pm
Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms
- Jan 4th, 2024 11:00 am
Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 2nd, 2024 9:05 pm
Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
- Dec 4th, 2023 9:00 pm
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
- Nov 21st, 2023 11:00 am
Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Nov 20th, 2023 9:00 pm
Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis
- Nov 13th, 2023 12:00 pm
Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
- Nov 9th, 2023 12:00 pm
Scroll